/Apple%20Inc%20logo%20on%20Apple%20store-by%20PhillDanze%20via%20iStock.jpg)
Apple (AAPL) ended July with a big milestone. On July 28, Apple briefly touched a $5 trillion market cap before closing at $340.08 per share. That made it the second company after Nvidia Corporation (NVDA) to reach that level.
Apple shares rose just 0.24% in the past month and 13.8% for 2026, beating the rest of the “Magnificent Seven.” Still, the sharp move may have gone too far, too fast. Apple’s 12-day rate of change versus the S&P 500 ETF Trust (SPY) hit roughly 17%, a level that has often been followed by short-term pullbacks.
Away from the stock-price headlines, Apple has continued to add to its hardware and manufacturing toolkit. European Commission filings showed that Apple acquired PlasmaSolve, a Czech firm that develops plasma-simulation software used to design and improve thin-film coatings for products such as the iPhone. It is Apple’s third small acquisition this year, after buying the team behind the Play app and data-observability startup SigScalr.
So, why is a company worth $5 trillion spending on plasma physics and coating chemistry?
Apple’s Financial Strength
Apple makes most of its money from selling premium devices such as the iPhone, Mac, iPad, and wearables, while its Services business adds a steady, high-margin revenue stream.
Apple shares have climbed 49.93% over the past 52 weeks and 11.61% so far this year.
But the stock is not cheap. It trades at 35.09 times forward price-to-earnings, well above the technology sector average of 23.53 times, so investors are clearly expecting continued solid growth.
Also, Apple pays a quarterly dividend. Its latest payment was $0.27 per share on May 11, 2026, giving it an annual dividend of $1.05 and a 0.35% yield. That is below the technology sector’s 1.37% average yield, but Apple’s 12.13% forward payout ratio leaves plenty of cash for buybacks, investments, and future dividend raises. The company has increased its dividend for 15 straight years.
Those resources were on display in fiscal Q3 2026. Revenue rose 16% year-over-year (YOY) to $109.42 billion, while net income reached $29.79 billion. Diluted EPS jumped 29% to $2.02, although that figure included a $0.11 per share benefit from tariff refunds, which also helped lift Apple's gross margin by roughly two percentage points to a June-quarter record of 50.1%.
iPhone revenue rose 22% to $54.3 billion, Mac sales increased 29% to $10.4 billion, and Services revenue grew 12% to $30.7 billion. Wearables revenue rose 6% to $7.9 billion, while iPad sales slipped 6% to $6.2 billion. Apple generated a record $34.4 billion in June-quarter operating cash flow and returned $33 billion to shareholders, including about $4 billion in dividends and equivalents and $25.8 billion in share repurchases.
Materials Science as a Competitive Lever
Apple acquired all of PlasmaSolve s.r.o. through a subsidiary and plans to bring in some of the Czech company’s employees. Apple did not announce the deal publicly. It came to light through a European Commission filing. Founded in 2016, PlasmaSolve developed MatSight, software that helps manufacturers model physical vapor deposition (PVD) and plasma-enhanced chemical vapor deposition (PECVD). These processes are used to apply very thin, scratch-resistant coatings to metal surfaces.
The technology could help Apple make future devices thinner and lighter without making them easier to damage. PVD coatings are already used on iPhone camera modules and titanium frames. By bringing PlasmaSolve’s simulation tools in-house, Apple could gain more control over the way in which it designs coatings and tests materials before production. The deal closed in April but did not become public until August, when it appeared under EU merger-disclosure rules.
This fits Apple's recent dealmaking style. In February, Apple bought the team behind Play, an Apple Design Award-winning SwiftUI prototyping app, to strengthen its design and developer tools. In March, Apple acquired SigScalr, the startup behind the open-source SigLens observability platform, to better track application performance across its AI and cloud systems. Like the PlasmaSolve deal, both acquisitions were disclosed through European Commission filings months after they closed.
Wall Street’s View and Long-Term Signals
Apple is set to report fiscal Q4 2026 earnings on Oct. 29. For the September quarter, Wall Street is looking for EPS of $1.99, up 7.57% from $1.85 a year ago. For the full 2026 fiscal year, analysts expect EPS of $8.76, a solid 17.43% jump from $7.46 in 2025.
Citi analyst Asiya Merchant raised her target on Apple to $365 from $315 on July 13 and kept a “Buy” rating, saying the company’s underlying fundamentals still support more upside even after roughly a 30% rally since March.
Bank of America analyst Wamsi Mohan lifted his target to $380, arguing that Apple is shifting from adding AI features to building a full AI platform, a move he thinks could generate $15 billion to $30 billion in extra revenue by fiscal 2030.
There are a few caution flags. GF Securities cut Apple to “Hold” on July 31, pointing to a global memory-chip shortage that could push iPhone 18 Pro pricing higher and weigh on demand.
Even so, all 42 analysts surveyed rate Apple a consensus “Moderate Buy,” and their average price target of $325.13 suggests 5.1% upside from where the stock currently trades.
Conclusion
PlasmaSolve is unlikely to move Apple’s revenue needle on its own, but that is not really the point. The acquisition fits Apple’s long-running strategy of quietly bringing specialized technology in-house to improve product durability, design flexibility, and manufacturing control. In that sense, it is strategically meaningful as another small building block in Apple’s broader hardware and AI-era innovation stack. As for the stock, Apple’s premium valuation and recent run-up leave it vulnerable to near-term volatility, especially if component costs rise. Still, strong cash flow, earnings momentum, and a deepening competitive moat suggest shares are more likely to trend higher over the longer term.
On the date of publication, Ebube Jones did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
